Warning letter
W & C dba The Apothecary: warning letter of Jul 20, 2017
FDA warning letter 508183 · Detroit District Office
Key facts
| Reference number | 508183 |
|---|---|
| Company | W & C dba The Apothecary |
| Subject | Compounding Pharmacy/Adulterated Drug Products |
| Issue date | Jul 20, 2017 |
| Posted date | Jul 20, 2017 |
| Issuing office | Detroit District Office |
| Product type | Drugs |
| CFR sections cited | 201.115, 211.42(c), 211.42(c)(10)(iv), 211.42(c)(10)(v), 211.113(b), 211.165(f) |
| Inspection city | Sartell |
| Inspection ZIP | 56377 |
| Inspection start date | Jun 6, 2016 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: